ISSN: 1300-7777 E-ISSN: 1308-5263
Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies [Turk J Hematol]
Turk J Hematol. Ahead of Print: TJH-35033 | DOI: 10.4274/tjh.2018.0007  

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies

Maria N. Gamaletsou1, Thomas J. Walsh2, Nikolaos V. Sipsas3
1St James University Hospital, The Leeds Teaching Hospitals NHS Trust, Leeds, UK
2Departments of Medicine, Pediatrics, and Microbiology & Immunology, Weill Cornell Medicine of Cornell University, New York, NY, USA
3Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Invasive fungal infections caused by drug-resistant organisms, are an emerging threat to heavily immunosuppressed patients with haematological malignancies. Modern early antifungal treatment strategies, such as prophylaxis, empirical and pre-emptive therapy result in long term exposure to antifungal agents, which is a major driving force for the development of resistance. The extended use of central venous catheters, the non-linear pharmacokinetics of certain antifungal agents, neutropenia, other forms of intense immunosuppression, and drug toxicities are other contributing factors. The widespread use of agricultural and industrial fungicides, with similar chemical structures and mechanisms of action, has resulted in development of environmental reservoirs for some drug-resistant fungi, especially azole-resistant Aspergillus species, which have been reported from four continents. The majority of resistant strains have the mutation TR34/L98H, a finding suggesting that the source of resistance is the environment. The globalemergence of new fungal pathogens with inherent resistance, such as Candida auris is a new public health threat. The most common mechanism of antifungal drug resistance is the induction of efflux pumps, which decrease intra-cellular drug concentration. Overexpression, depletion, and alteration of the drug target are other mechanisms of resistance. Mutations in the ERG11 gene alter the protein structure of C-demethylase, reducing the efficacy of antifungal triazoles. Candida species become echinocandin-resistant by mutations in FKS genes. A shift in the epidemiology ofCandida towards resistant non-albicans Candida spp has emerged among patients with haematological malignancies. There is no definite association between antifungal resistance, as defined by elevated MICs, and clinical outcomes in this population. Detection of genes or mutations conferring resistance with the use of molecular methods may offer better predictive value in certain cases. Treatment options for resistant fungal infections are limited and new drugs with novel mechanisms of actions are needed. Prevention of resistance through antifungal stewardship programs is of paramount importance.

Keywords: Invasive fungal infections, antifungal resistance, hematological malignancies, new antifungal agents




Corresponding Author: Maria N. Gamaletsou, Türkiye


TOOLS
Uncorrected Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686